A Drug Enforcement Administration (DEA) judge is pausing proceedings in an ongoing hearing on the Trump administration’s marijuana rescheduling proposal and asking asking agency officials and other participants to weigh in after a federal watchdog issued a report finding that there are “gaps” in the government’s process for evaluating controlled substances.
DEA Chief Administrative Law Judge Derek Julius on Tuesday issued a stay in response to a motion from a drug testing industry association and other participants who want a recent Government Accountability Office (GAO) report on drug scheduling to be entered into the record for the hearing, which took testimony in June and July.
Until now, the only expected remaining step in the proceedings was for Julius to issue his own recommendation on marijuana rescheduling to the DEA administrator, who would then make a final determination on the policy.
But the judge granted the motion for a stay filed by the National Drug and Alcohol Association (NDASA), DUID Victim Voices and Kenneth Finn, M.D.—parties opposed to cannabis rescheduling that participated in the hearing and who now want the GAO report included as part of the record.
That report found, among other things that DEA “does not have any policies
Read full article on Marijuana Moment
